Korro Bio, Inc.
KRRO· Nasdaq
KRROKorro Bio, Inc.
Filed Nov 18, 2019 · 10-Q · 49 days after period end · 0001564590-19-043670
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Revenue | $24.24M | — |
| Net Income | -$575.00K | -$5.14M |
| EPS Diluted | -$0.73 | -$3.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Korro Bio, Inc. · CIK 1703647 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 18, 2019 · 49 d after period end
